Researchers warn that if the US is to avoid the impact on hospitals Italy faces as a result of the coronavirus outbreak, people who are even mildly symptomatic must self isolate to minimize disease transmission. Read More
Researchers explore why COVID-19 is more deadly compared to the flu and other viruses. Read More
A patient who tested positive for COVID-19 developed acute necrotizing encephalitis (ANE) as a result of the coronavirus infection. An MRI scan revealed the patient had lesions in the thalamus and temporal lobes, areas of the brain implicated in consciousness, sensation, and memory function. Researchers advise doctors to look out for COVID-19 patients who present with altered levels of consciousness, as this may be symptomatic of ANE. Read More
Based on data from COVID-19 patients from Wuhan, China, that died as a result of the infection, researchers have identified many symptom commonalities the patients shared. Read More
Structural mapping of both SARS and SARS-CoV-2, the virus that causes COVID-19, reveals an almost identical site on both coronaviruses to which the CR3022 antibody binds. This suggests a functionally important and vulnerable site for this family of coronaviruses. Read More
SARS-CoV-2, the virus responsible for COVID-19, can linger for days in sewage and water systems and remain infectious. Researchers call for new studies to determine if current water treatment methods are efficient and effective at killing SARS-CoV-2. Read More
Wearing face masks significantly reduced the amounts of airborne virus particles expelled from infected patients. Findings suggest surgical-style face masks could slow the transmission of coronavirus and influenza viruses. Read More
Aerosolized particles produced while speaking may be enough to transmit coronavirus infection by those who are asymptomatic. Read More
Hydroxychloroquine and azithromycin, two drugs touted as potential coronavirus therapeutics, could increase the risk of heart arrhythmias, cardiologists say. Read More
A new COVID-19 vaccine produces antibodies specific to SARS-CoV-2 at quantities believed sufficient for neutralizing the virus, a mouse model study reveals. The new vaccine using an innovative microneedle array on fingertip-sized pads, which increases the vaccine potency. Read More
Study reports viral shedding of SARS-CoV-2 occurs in the upper respiratory tract during early COVID-19 infection when symptoms are mild or hardly noticeable. Read More
hrsACE2, a genetically modified protein already being tested to prevent lung disease, reduces the viral growth of SARS-CoV-2 by a factor of 1,000 to 5,000 in human cell cultures. Researchers believe the enzyme copy lures the virus to attach itself to the copy, rather than human lung cells. The findings suggest hrsACE2 could significantly block the early stages of SARS-CoV-2 infections and prevent COVID-19 from becoming severe. Read More
